Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 1
1996 3
1997 3
1998 5
1999 1
2000 3
2001 3
2002 4
2003 4
2004 8
2005 3
2006 7
2007 7
2008 5
2009 4
2010 1
2011 6
2012 5
2013 3
2014 4
2015 7
2016 4
2017 6
2018 7
2019 6
2020 5
2021 8
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
Jabbour E, Sasaki K, Short NJ, Ravandi F, Huang X, Khoury JD, Kanagal-Shamanna R, Jorgensen J, Khouri IF, Kebriaei P, Jain N, Alvarado Y, Kadia TM, Paul S, Garcia-Manero G, Dabaja BS, Burger JA, DiNardo CD, Daver NA, Montalban-Bravo G, Yilmaz M, Ohanian M, Ferrajoli A, Jacob J, Rostykus M, Garris R, O'Brien S, Kantarjian HM. Jabbour E, et al. Among authors: khouri if. Cancer. 2021 Jun 15;127(12):2025-2038. doi: 10.1002/cncr.33469. Epub 2021 Mar 19. Cancer. 2021. PMID: 33740268 Free article.
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors.
Jabbour EJ, Sasaki K, Haddad FG, Issa GC, Garcia-Manero G, Kadia TM, Jain N, Yilmaz M, DiNardo CD, Patel KP, Kanagal-Shamanna R, Champlin R, Khouri IF, Dellasala S, Pierce SA, Kantarjian H. Jabbour EJ, et al. Among authors: khouri if. Am J Hematol. 2023 Apr;98(4):658-665. doi: 10.1002/ajh.26852. Epub 2023 Jan 31. Am J Hematol. 2023. PMID: 36683287 Free article.
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.
Al-Juhaishi T, Wang Y, Milton DR, Xu-Monette ZY, Jabbour E, Daher M, Im JS, Bashir Q, Iyer SP, Marin D, Olson AL, Popat U, Qazilbash M, Rondon G, Gulbis AM, Champlin RE, Young KH, Khouri IF. Al-Juhaishi T, et al. Among authors: khouri if. Bone Marrow Transplant. 2023 Sep;58(9):1000-1007. doi: 10.1038/s41409-023-02006-3. Epub 2023 May 18. Bone Marrow Transplant. 2023. PMID: 37198234
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Bashir Q, Milton DR, Popat UR, Kebriaei P, Hosing C, Khouri IF, Rezvani K, Nieto Y, Oran B, Srour SA, Saini NY, Olson AL, Ahmed S, Al-Atrash G, Rondon G, Konopleva MY, Champlin RE, Shpall EJ, Qazilbash MH, Pemmaraju N. Bashir Q, et al. Among authors: khouri if. Bone Marrow Transplant. 2022 Jan;57(1):51-56. doi: 10.1038/s41409-021-01478-5. Epub 2021 Oct 11. Bone Marrow Transplant. 2022. PMID: 34629467 Free PMC article.
Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.
Saliba RM, Veltri L, Rondon G, Chen J, Al-Atrash G, Alousi A, Martinez C, Augustine L, Hosing CM, Oran B, Rezvani K, Shpall EJ, Kebriaei P, Khouri IF, Popat U, Champlin RE, Ciurea SO. Saliba RM, et al. Among authors: khouri if. Haematologica. 2021 Jan 1;106(1):269-274. doi: 10.3324/haematol.2019.227371. Haematologica. 2021. PMID: 32107328 Free PMC article. No abstract available.
118 results